BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31391340)

  • 1. Activated gp130 signaling selectively targets B cell differentiation to induce mature lymphoma and plasmacytoma.
    Scherger AK; Al-Maarri M; Maurer HC; Schick M; Maurer S; Öllinger R; Gonzalez-Menendez I; Martella M; Thaler M; Pechloff K; Steiger K; Sander S; Ruland J; Rad R; Quintanilla-Martinez L; Wunderlich FT; Rose-John S; Keller U
    JCI Insight; 2019 Aug; 4(15):. PubMed ID: 31391340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GP130 activation induces myeloma and collaborates with MYC.
    Dechow T; Steidle S; Götze KS; Rudelius M; Behnke K; Pechloff K; Kratzat S; Bullinger L; Fend F; Soberon V; Mitova N; Li Z; Thaler M; Bauer J; Pietschmann E; Albers C; Grundler R; Schmidt-Supprian M; Ruland J; Peschel C; Duyster J; Rose-John S; Bassermann F; Keller U
    J Clin Invest; 2014 Dec; 124(12):5263-74. PubMed ID: 25384216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
    Pastuschek J; Poetzsch J; Morales-Prieto DM; Schleußner E; Markert UR; Georgiev G
    J Reprod Immunol; 2015 Apr; 108():48-55. PubMed ID: 25817464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of gp130 signaling in T cells drives T
    Baumgartner F; Bamopoulos SA; Faletti L; Hsiao HJ; Holz M; Gonzalez-Menendez I; Solé-Boldo L; Horne A; Gosavi S; Özerdem C; Singh N; Liebig S; Ramamoorthy S; Lehmann M; Demel U; Kühl AA; Wartewig T; Ruland J; Wunderlich FT; Schick M; Walther W; Rose-John S; Haas S; Quintanilla-Martinez L; Feske S; Ehl S; Glauben R; Keller U
    Sci Signal; 2024 Feb; 17(824):eadc9662. PubMed ID: 38377177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gp130 and ras mediated signaling in human plasma cell line INA-6: a cytokine-regulated tumor model for plasmacytoma.
    Burger R; Guenther A; Bakker F; Schmalzing M; Bernand S; Baum W; Duerr B; Hocke GM; Steininger H; Gebhart E; Gramatzki M
    Hematol J; 2001; 2(1):42-53. PubMed ID: 11920233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron-dependent CDK1 activity promotes lung carcinogenesis via activation of the GP130/STAT3 signaling pathway.
    Kuang Y; Guo W; Ling J; Xu D; Liao Y; Zhao H; Du X; Wang H; Xu M; Song H; Wang T; Jing B; Li K; Hu M; Wu W; Deng J; Wang Q
    Cell Death Dis; 2019 Apr; 10(4):297. PubMed ID: 30931929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GP130 signaling and the control of naïve pluripotency in humans, monkeys, and pigs.
    Bourillot PY; Santamaria C; David L; Savatier P
    Exp Cell Res; 2020 Jan; 386(1):111712. PubMed ID: 31697928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse large B-cell lymphoma-derived exosomes push macrophage polarization toward M2 phenotype via GP130/STAT3 signaling pathway.
    Ling HY; Yang Z; Wang PJ; Sun Y; Ju SG; Li J; Fu JX
    Chem Biol Interact; 2022 Jan; 352():109779. PubMed ID: 34922904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.
    Hirano T; Ishihara K; Hibi M
    Oncogene; 2000 May; 19(21):2548-56. PubMed ID: 10851053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forced dimerization of gp130 leads to constitutive STAT3 activation, cytokine-independent growth, and blockade of differentiation of embryonic stem cells.
    Stuhlmann-Laeisz C; Lang S; Chalaris A; Krzysztof P; Enge S; Eichler J; Klingmüller U; Samuel M; Ernst M; Rose-John S; Scheller J
    Mol Biol Cell; 2006 Jul; 17(7):2986-95. PubMed ID: 16624864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6 promotes MYC-induced B cell lymphomagenesis independent of STAT3.
    Petrenko O; Li J; Cimica V; Mena-Taboada P; Shin HY; D'Amico S; Reich NC
    PLoS One; 2021; 16(3):e0247394. PubMed ID: 33651821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
    Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
    Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated Rac1 requires gp130 for Stat3 activation, cell proliferation and migration.
    Arulanandam R; Geletu M; Feracci H; Raptis L
    Exp Cell Res; 2010 Mar; 316(5):875-86. PubMed ID: 19852956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebi3 promotes T- and B-cell division and differentiation via STAT3.
    Ma N; Fang Y; Xu R; Zhai B; Hou C; Wang X; Jiang Z; Wang L; Liu Q; Han G; Wang R
    Mol Immunol; 2019 Mar; 107():61-70. PubMed ID: 30660991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional involvement of Daxx in gp130-mediated cell growth and survival in BaF3 cells.
    Muromoto R; Kuroda M; Togi S; Sekine Y; Nanbo A; Shimoda K; Oritani K; Matsuda T
    Eur J Immunol; 2010 Dec; 40(12):3570-80. PubMed ID: 21108476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-autonomous hepatocyte-specific GP130 signaling is sufficient to trigger a robust innate immune response in mice.
    Schumacher N; Yan K; Gandraß M; Müller M; Krisp C; Häsler R; Carambia A; Nofer JR; Bernardes JP; Khouja M; Thomsen I; Chalupsky K; Bolik J; Hölscher C; Wunderlich T; Herkel J; Rosenstiel P; Schramm C; Schlüter H; Renné T; Mittrücker HW; Rose-John S; Schmidt-Arras D
    J Hepatol; 2021 Feb; 74(2):407-418. PubMed ID: 32987028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation.
    Park SJ; Nakagawa T; Kitamura H; Atsumi T; Kamon H; Sawa S; Kamimura D; Ueda N; Iwakura Y; Ishihara K; Murakami M; Hirano T
    J Immunol; 2004 Sep; 173(6):3844-54. PubMed ID: 15356132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
    Wang Y; Ma H; Zhao C; Liu T; Yan D; Jou D; Li H; Zhang C; Lü J; Li C; Lin J; Li S; Lin L
    Oncotarget; 2017 May; 8(20):33683-33693. PubMed ID: 28430601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Interleukin-6 Receptor Signaling by TNF Receptor-Associated Factor 2 and 5 During Differentiation of Inflammatory CD4
    Nagashima H; Ishii N; So T
    Front Immunol; 2018; 9():1986. PubMed ID: 30214449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.